Sponsored By

Devils Claw is NYAGs Current Supplement Target

Eric Schneiderman’s office said the Harpagophytum zeyheri species of devil’s claw is less desirable than Harpagophytum procumbens. The natural products industry disagrees.

September 17, 2015

The New York Attorney General sent cease-and-desist letters to manufacturers of devil’s Claw supplements, saying DNA barcoding tests revealed that instead of containing the devil’s claw strain Harpagophytum procumbens, it contained the strain Harpagophytum zeyheri.

Schneiderman’s office said the zeyheri species is less desirable. The natural products industry disagrees.

Watch this INSIDER TV news desk to get the industry’s take.

Read more: “New York Attorney General Schneiderman Targets ‘Devil’s Claw’ Supplements

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like